These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 8148147
1. The distinction between multiple retinal pigment epithelial hamartomata (MRPEH) in familial adenomatous polyposis (FAP) and congenital hypertrophy of the retinal pigment epithelium (CHRPE). Hennessy MP, Collins F, Coroneo MT. Aust N Z J Ophthalmol; 1993 Nov; 21(4):275-6. PubMed ID: 8148147 [No Abstract] [Full Text] [Related]
2. Congenital hypertrophy of the retinal pigment epithelium serves as a clinical marker in a family with familial adenomatous polyposis. Parisi ML. J Am Optom Assoc; 1995 Feb; 66(2):106-12. PubMed ID: 7714311 [Abstract] [Full Text] [Related]
3. Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis. Novel criteria of assessment and correlations with constitutional adenomatous polyposis coli gene mutations. Valanzano R, Cama A, Volpe R, Curia MC, Mencucci R, Palmirotta R, Battista P, Ficari F, Mariani-Costantini R, Tonelli F. Cancer; 1996 Dec 01; 78(11):2400-10. PubMed ID: 8941012 [Abstract] [Full Text] [Related]
4. Congenital hypertrophy of retinal pigment epithelium (CHRPE) as a marker for familial adenomatous polyposis (FAP). Bertario L, Bandello F, Rossetti C, Sala P, Fortini E, Spinelli P, Gennari L, Pietroiusti M, Presciuttini S. Eur J Cancer Prev; 1993 Jan 01; 2(1):69-75. PubMed ID: 8381318 [Abstract] [Full Text] [Related]
5. In patients with a positive family history of familial adenomatous polyposis can the condition be diagnosed from the presence of congenital hypertrophy of the retinal pigment epithelium detected via an eye examination: A systematic review. Rehan S, Aye K. Clin Exp Ophthalmol; 2020 Jan 01; 48(1):98-116. PubMed ID: 31525261 [Abstract] [Full Text] [Related]
6. Congenital hypertrophy of the retinal pigment epithelium and familial adenomatous polyposis. McKay DL. Aust N Z J Ophthalmol; 1993 Feb 01; 21(1):3-6. PubMed ID: 8388223 [Abstract] [Full Text] [Related]
7. The presence of congenital hypertrophy of the retinal pigment epithelium in a subgroup of patients with adenomatous polyposis coli mutations. Reck AC, Bunyan D, Eccles D, Humphry R. Eye (Lond); 1997 Feb 01; 11 ( Pt 3)():298-300. PubMed ID: 9373466 [Abstract] [Full Text] [Related]
8. Assessment of the value of congenital hypertrophy of the retinal pigment epithelium as an ocular marker for familial adenomatous polyposis coli. Hickey-Dwyer MU, Willoughby CE. Eye (Lond); 1993 Feb 01; 7 ( Pt 4)():562-4. PubMed ID: 8253239 [Abstract] [Full Text] [Related]
10. Lack of association among typical congenital hypertrophy of the retinal pigment epithelium, adenomatous polyposis, and Gardner syndrome. Shields JA, Shields CL, Shah PG, Pastore DJ, Imperiale SM. Ophthalmology; 1992 Nov 01; 99(11):1709-13. PubMed ID: 1333580 [Abstract] [Full Text] [Related]
12. Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis. Touriño R, Conde-Freire R, Cabezas-Agrícola JM, Rodríguez-Aves T, López-Valladares MJ, Otero-Cepeda JL, Capeans C. Int Ophthalmol; 2004 Mar 01; 25(2):101-12. PubMed ID: 15290889 [Abstract] [Full Text] [Related]
18. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) and familial adenomatous polyposis (FAP). Rossato M, Rigotti M, Grazia M, Turco AE, Bonomi L. Acta Ophthalmol Scand; 1996 Aug 01; 74(4):338-42. PubMed ID: 8883546 [Abstract] [Full Text] [Related]